A Clinician’s Perspective on the Mechanism of β(3)-Adrenoceptor Agonists in the Bladder

Gelijkaardige items

• On the Site and Mechanism of Action of β(3)-Adrenoceptor Agonists in the Bladder
  door: Andersson, Karl Erik
  Gepubliceerd in: (2017)
• On the Site and Mechanism of Action of β-Adrenoceptor Agonists in the Bladder
  door: Karl Erik Andersson
  Gepubliceerd in: (2017-03-01)
• The β(3)‐adrenoceptor agonist mirabegron increases human atrial force through β(1)‐adrenoceptors: an indirect mechanism?
  door: Mo, Weilan, et al.
  Gepubliceerd in: (2017)
• Challenges in β(3)-Adrenoceptor Agonist Drug Development
  door: Arch, Jonathan R. S.
  Gepubliceerd in: (2011)
• The efficacy and tolerability of mirabegron, a β3 adrenoceptor agonist, in patients with symptoms of overactive bladder
  door: Thiagamoorthy, Ganesh, et al.
  Gepubliceerd in: (2016)